In contrast to all that, many investors prefer to focus on companies like Boston Scientific (NYSE:BSX), which has not only revenues, but also profits. While this doesn't necessarily speak to whether ...

The stock's fall snapped a two-day winning streak.

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

In a wide manufacturing room with white walls and low ceilings, Boston Scientific employees combine components into finished ...

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific Corp. closed 9.34% short of its 52-week high of $107.17, which the company reached on February 5th.

Boston Scientific (NYSE:BSX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” rating in a ...

The money will support an ongoing pivotal trial of 4C Medical Technologies' transcatheter mitral valve replacement device in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Medical device giant Boston Scientific has announced that it has signed a definitive agreement to acquire Israeli medical ...